Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $66.30 | Total: $331.50 |
| 1 | 10 | $56.16 | Total: $561.60 |
| 1 | 25 | $47.58 | Total: $1,189.50 |
| 1 | 50 | $40.56 | Total: $2,028.00 |
| 1 | 100 | $35.10 | Total: $3,510.00 |
Overview
Ertiprotafib (PTP 112), a selective and potent inhibitor of protein tyrosine phosphate 1B (PTP1B) and IkappaB kinase ? (IKK-?), is a novel insulin sensitizer with potential anticancer activity for the study of type 2 diabetes and breast cancer.
Chemical Properties
| Molecular Formula | C31H27BrO3S |
| Molecular Weight | 559.51 |
| CAS Numbers | 251303-04-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC=1C2=C(C=3C(C(Br)=C2SC1C)=CC=CC3)C4=CC(C)=C(O[C@H](CC5=CC=CC=C5)C(O)=O)C(C)=C4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Shrestha S, et al. PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta [IKK-beta]. Bioorg Med Chem Lett. 2007 May 15;17[10] 2728-30. Epub 2007 Mar 3.